Hodgkin Disease—An Ever-Evolving Therapy
Therapy of Hodgkin lymphoma (HL) is a rapidly changing field due to plenty of currently emerging data. Treatment approaches are currently based on tailoring of therapy in order to achieve a maximal response with minimal toxicity. Since the median age of HL patients is 33 years and their prospective...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2014-10-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=442 |